Design and validation of a neutral protein scaffold for the presentation of peptide aptamers

被引:62
作者
Woodman, R
Yeh, JTH
Laurenson, S
Ferrigno, PK
机构
[1] MRC, Hutchison Res Ctr, Canc Cell Unit, Cambridge CB2 2XZ, England
[2] Univ Cambridge, Canc Res UK, Dept Oncol, Hutchison Res Ctr,MRC, Cambridge CB2 2XZ, England
基金
英国医学研究理事会;
关键词
peptide aptamer; scaffold protein; constrained peptide; stefin A;
D O I
10.1016/j.jmb.2005.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pepticle aptamers are peptides constrained and presented by a scaffold protein that are used to study protein function in cells. They are able to disrupt protein-protein interactions and to constitute recognition modules that allow the creation of a molecular toolkit for the intracellular analysis of protein function. The success of peptide aptamer technology is critically dependent on the performance of the scaffold. Here, we describe a rational approach to the design of a new peptide aptamer scaffold. We outline the qualities that an ideal scaffold would need to possess to be broadly useful for in vitro and in vivo studies and apply these criteria to the design of a new scaffold, called STM. Starting from the, small, stable intracellular protease inhibitor stefin A, we have engineered a biologically neutral scaffold that retains the stable conformation of the parent protein. We show that STM is able to present peptides that bind to targets of interest, both in the context of known interactors and in library screens. Molecular tools based on our scaffold are likely to be used in a wide range of studies of biological pathways, and in the validation of drug targets. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1118 / 1133
页数:16
相关论文
共 51 条
[1]  
Abedi M, 2001, BMC Mol Biol, V2, P10, DOI 10.1186/1471-2199-2-10
[2]   Green fluorescent protein as a scaffold for intracellular presentation of peptides [J].
Abedi, MR ;
Caponigro, G ;
Kamb, A .
NUCLEIC ACIDS RESEARCH, 1998, 26 (02) :623-630
[3]   Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold [J].
Beste, G ;
Schmidt, FS ;
Stibora, T ;
Skerra, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :1898-1903
[4]   High-affinity binders selected from designed ankyrin repeat protein libraries [J].
Binz, HK ;
Amstutz, P ;
Kohl, A ;
Stumpp, MT ;
Briand, C ;
Forrer, P ;
Grütter, MG ;
Plückthun, A .
NATURE BIOTECHNOLOGY, 2004, 22 (05) :575-582
[5]   Isolation of peptide aptamers that inhibit intracellular processes [J].
Blum, JH ;
Dove, SL ;
Hochschild, A ;
Mekalanos, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) :2241-2246
[6]   THE 2.0 A X-RAY CRYSTAL-STRUCTURE OF CHICKEN EGG-WHITE CYSTATIN AND ITS POSSIBLE MODE OF INTERACTION WITH CYSTEINE PROTEINASES [J].
BODE, W ;
ENGH, R ;
MUSIL, D ;
THIELE, U ;
HUBER, R ;
KARSHIKOV, A ;
BRZIN, J ;
KOS, J ;
TURK, V .
EMBO JOURNAL, 1988, 7 (08) :2593-2599
[7]   Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].
Bottger, A ;
Bottger, V ;
Sparks, A ;
Liu, WL ;
Howard, SF ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (11) :860-869
[8]  
BRZIN J, 1983, H-S Z PHYSIOL CHEM, V364, P1475, DOI 10.1515/bchm2.1983.364.2.1475
[9]   Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells [J].
Buerger, C ;
Nagel-Wolfrum, K ;
Kunz, C ;
Wittig, I ;
Butz, K ;
Hoppe-Seyler, F ;
Groner, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37610-37621
[10]   Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein [J].
Butz, K ;
Denk, C ;
Ullmann, A ;
Scheffner, M ;
Hoppe-Seyler, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6693-6697